Doros Platika, M.D. has served as the President and Chief Executive Officer of the Pittsburgh Life Sciences Greenhouse.  After leaving the Pittsburgh Life Sciences Greenhouse at the end of November 2006, Dr. Platika is embarking on a new role: helping to get funding to study the world's oldest people.  Dr. Platika is the chairman of the Supercentenarian Research Foundation, a new organization designed to pump funding into studies that look at why supercentenarians, or people who have lived more than 110 years, have survived as long as they have. He also serves as the Chairman of its Board of Directors of Cohera Medical Inc. a Pittsburgh based company that is working to commercialize biodegradable surgical adhesives.

Dr. Platika earned his B.A. from Reed College, majoring in Biology and Psychology, and he received his M.D., from the State University of New York at Stony Brook, School of Medicine. Dr. Platika completed residencies in both medicine and neurology at the Massachusetts General Hospital, where he served as a chief resident.  He completed his post-doctoral study at the Massachusetts Institute of Technology’s Whitehead Institute in gene therapy, and at Massachusetts General Hospital, Harvard Medical School, in developmental biology.  Dr. Platika has also served on the faculty of both Harvard Medical School and the Albert Einstein College of Medicine.

Prior to joining the PLSG Dr. Platika was with a Boston-based venture capital firm, focusing on investment in life sciences companies, where he was a scientific advisor.  He has held various positions in several other life science companies throughout the U.S. He is a member of the American Medical Association, the New York Academy of Sciences, the Massachusetts Medical Society, the American Association of the Advancement of Science, the Massachusetts Neurologic Association, the Society for Neuroscience, the American Academy of Neurology, MENSA and the United States Chess Federation.